October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University Hospitals (UH) Harrington Heart & Vascular Institute is at the forefront of studying ...
VIVA
This channel contains news about the annual Vascular Interventional Advances (VIVA) conference. VIVA is a premier conference for new techniques and technologies to treat vascular disease. This includes the areas of peripheral artery disease (PAD), critical limb ischemia (CLI), endovascular repair and venous therapies.
November 3, 2022 — Medtronic, a global leader in medical technology, today announced the results of two clinical studies ...
November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...
November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...
October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...
September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INte ...
October 20, 2021 — Philips, a global leader in health technology and intravascular ultrasound (IVUS) solutions ...
October 20, 2021 — 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a late-breaking ...
October 20, 2021 — Boston Scientific Corporation announced positive data for the Eluvia Drug-Eluting Vascular Stent ...
The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting planned for Aug. 9-13 appeared to ...
October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...
November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...
November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...
November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...
November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...